Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ALD
WisdomTree Asia Local Debt Fund
$44.39
-0.2%
$44.39
$41.78
$46.65
$17.76MN/A7,986 shs1,400 shs
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$0.50
+1.0%
C$0.53
C$0.45
C$0.69
C$9.11M1.6915,002 shs2,000 shs
Ampol Limited stock logo
CTXAF
Ampol
$16.30
$15.82
$14.46
$23.51
N/AN/A14,550 shsN/A
Neste Oyj stock logo
NTOIY
Neste Oyj
$6.74
+0.7%
$5.47
$3.75
$12.07
N/AN/A126,453 shs19,511 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ALD
WisdomTree Asia Local Debt Fund
0.00%0.00%0.00%0.00%0.00%
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00%+2.06%-1.00%-14.66%-6.60%
Ampol Limited stock logo
CTXAF
Ampol
0.00%0.00%0.00%+12.72%-17.93%
Neste Oyj stock logo
NTOIY
Neste Oyj
0.00%+1.98%+25.14%+47.03%-24.41%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
0.3777 of 5 stars
0.01.01.70.00.80.01.3
Neste Oyj stock logo
NTOIY
Neste Oyj
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ALD
WisdomTree Asia Local Debt Fund
0.00
N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
0.00
N/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
0.00
N/AN/AN/A
Neste Oyj stock logo
NTOIY
Neste Oyj
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
C$16.62M0.55C$0.41 per share1.20C$0.83 per share0.59
Ampol Limited stock logo
CTXAF
Ampol
N/AN/AN/AN/AN/AN/A
Neste Oyj stock logo
NTOIY
Neste Oyj
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ALD
WisdomTree Asia Local Debt Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
-C$2.61M-C$0.15N/AN/A-15.73%-15.60%-8.26%N/A
Ampol Limited stock logo
CTXAF
Ampol
N/A$1.848.84N/AN/AN/AN/A8/18/2025 (Estimated)
Neste Oyj stock logo
NTOIY
Neste Oyj
N/A$0.5412.58N/AN/AN/AN/A7/24/2025 (Estimated)

Latest NTOIY, ALD, CTXAF, and CTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025N/A
Neste Oyj stock logo
NTOIY
Neste Oyj
-$0.0160N/AN/AN/A$4.92 billionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ALD
WisdomTree Asia Local Debt Fund
$0.942.12%N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/AN/AN/AN/AN/A
Ampol Limited stock logo
CTXAF
Ampol
$0.171.04%N/A9.22%N/A
Neste Oyj stock logo
NTOIY
Neste Oyj
$0.253.65%N/A45.88%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ALD
WisdomTree Asia Local Debt Fund
N/AN/AN/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
5.77
2.70
2.29
Ampol Limited stock logo
CTXAF
Ampol
N/AN/AN/A
Neste Oyj stock logo
NTOIY
Neste Oyj
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ALD
WisdomTree Asia Local Debt Fund
N/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
N/A
Ampol Limited stock logo
CTXAF
Ampol
10.16%
Neste Oyj stock logo
NTOIY
Neste Oyj
0.01%

Insider Ownership

CompanyInsider Ownership
ALD
WisdomTree Asia Local Debt Fund
N/A
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
10.87%
Ampol Limited stock logo
CTXAF
Ampol
N/A
Neste Oyj stock logo
NTOIY
Neste Oyj
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ALD
WisdomTree Asia Local Debt Fund
97,000400,000N/ANot Optionable
Crescita Therapeutics Inc. stock logo
CTX
Crescita Therapeutics
6218.41 millionN/ANot Optionable
Ampol Limited stock logo
CTXAF
Ampol
9,000N/AN/ANot Optionable
Neste Oyj stock logo
NTOIY
Neste Oyj
5,942N/AN/ANot Optionable

Recent News About These Companies

Neste price target lowered to EUR 7.50 from EUR 10 at UBS
Neste price target lowered to EUR 12 from EUR 14 at RBC Capital
Neste price target lowered to EUR 10.40 from EUR 15 at Morgan Stanley
Neste price target lowered to EUR 15 from EUR 18 at Barclays
Neste removed from European Conviction List at Goldman Sachs
Neste downgraded to Hold from Buy at Berenberg
Neste price target lowered to EUR 11 from EUR 16 at Citi
Neste's Market Free-Fall May Continue
Neste price target lowered to EUR 14 from EUR 18 at RBC Capital
Neste price target lowered to EUR 18 from EUR 22 at Barclays
Neste Hits 2016 Low After Loss, Dividend Policy Cancellation
Neste Hits 2016 Low After Loss, Dividend Policy Cancellation
Finland's Neste to cut around 600 jobs
Neste price target lowered to $8 from $10 at TD Cowen
Neste price target lowered to EUR 15 from EUR 18 at Morgan Stanley
RBC Capital Reaffirms Their Hold Rating on Neste Corporation (0O46)
Neste Corporation (0O46) Gets a Buy from UBS

New MarketBeat Followers Over Time

Top Headlines

View All Headlines

WisdomTree Asia Local Debt Fund NYSEARCA:ALD

$44.39 -0.10 (-0.22%)
As of 03/14/2019

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; thermal systems, as well as wireless connectivity and management services. The company's Honeywell Building Technologies segment offers software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance, and upgrades of systems. Its Performance Materials and Technologies segment offers automation control, instrumentation, and software and related services; catalysts and adsorbents, equipment, and consulting; and materials to manufacture end products, such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, as well as provides reduced and low global-warming-potential materials based on hydrofluoro-olefin technology. The company's Safety and Productivity Solutions segment provides personal protection equipment, apparel, gear, and footwear; gas detection technology; cloud-based notification and emergency messaging; mobile devices and software; supply chain and warehouse automation equipment, and software solutions; custom-engineered sensors, switches, and controls; and data and asset management productivity software solutions. The company was founded in 1906 and is headquartered in Charlotte, North Carolina.

Crescita Therapeutics stock logo

Crescita Therapeutics TSE:CTX

C$0.50 +0.01 (+1.02%)
As of 11:37 AM Eastern

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.

Ampol stock logo

Ampol OTCMKTS:CTXAF

$16.30 0.00 (0.00%)
As of 06/27/2025

Ampol Limited purchases, refines, distributes, and markets petroleum products in Australia, New Zealand, Singapore, and the United States. The company operates through Convenience Retail, Z Energy, and Fuels and Infrastructure segments. The Convenience Retail segment sells fuels through Ampol's network of stores. The Fuels and Infrastructure segment wholesales fuels and lubricant supplies. The Z Energy segment distributes fuel in the New Zealand market. It distributes its products through depots, terminals, pipelines, and service station sites. The company sells fuels to various customers in defense, mining, transport, marine, agriculture, aviation, and other commercial and industrial sectors. The company was formerly known as Caltex Australia Limited and changed its name to Ampol Limited in May 2020. The company was founded in 1900 and is headquartered in Alexandria, Australia.

Neste Oyj stock logo

Neste Oyj OTCMKTS:NTOIY

$6.74 +0.05 (+0.75%)
As of 03:51 PM Eastern

Neste Oyj provides renewable diesel and sustainable aviation fuel in Finland, and other Nordic countries, Baltic Rim, other European countries, North and South America, and internationally. The company operates in four segments: Renewable Products, Oil Products, Marketing & Services, and Others. The Renewable Products segment produces, markets, and sells renewable diesel, sustainable aviation fuel, renewable solvents, and feedstock for bioplastics to wholesale markets. The Oil Products segment produces, markets, and sells diesel, gasoline, aviation and marine fuels, light and heavy fuel oils, and gasoline components, as well as special fuels, such as small-engine gasoline, solvents, liquid gases, and bitumen. This segment serves retailers and distributors, oil majors and trading companies, petrochemicals companies, and companies marketing lubricants and solvents, as well as road transportation, non-road uses, aviation and marine sectors. The Marketing & Services segment markets and sells cleaner fuels and oil products, and associated services to private motorists, transport companies, customers in aviation, shipping, industrial and agricultural sectors, municipalities, farmers, and heating oil customers through a network of service stations, as well as direct sales and distributors. The Others segment offers engineering solutions. The company was formerly known as Neste Oil Oyj and changed its name to Neste Oyj in June 2015. Neste Oyj was founded in 1948 and is headquartered in Espoo, Finland.